12:00 – 12:45  Registration

12:45 – 13:00  Welcome from the Co-Chairs
Keith Barton and Kuldev Singh

13:00 – 13:30  Endponts for Macular Therapeutic Trails: Is it all about Vision or should Anatomy Matter?

13:30 – 14:00  Retina Innovation in the 2020’s
Moderators: Borja Corcostegui and Paulo Stanga

14:00 – 14:50  Company Presentations 1

14:50 – 15:20  Networking Break

15:20 – 15:30  Is Retina Overheated for Investors? 
Perspective by Nanna Luneborg, Novo Ventures

15:30 – 16:00  Is Retina Overheated for Investors 
Panel discussion, Moderator: Nanna Luneborg (Novo Ventures)

16:00 – 16:30  Safety, Vectors and Routes of Delivery for Stem Cells and Gene Therapy
Moderators: José-Alain Sahel and Bart Leroy

16:30 – 17:20  Company Presentations 2

17:20 – 17:50  Networking Break

17:50 – 18:20  The Role of OCT Angiography and Other Imaging Devices
Moderators: Francesco Bandello and Tien Yin Wong

18:20 – 18:50  Novel Pharmaceutical Agents and Delivery Approaches
Moderator: Eugene de Juan

18:50 – 19:20  Vitreo-Retinal Surgery and Robotics
Moderators: Steve Charles and Stanislao Rizzo

19:20 – 19:50  Machine Learning and Artificial Intelligence: Added Value or Passing Fad?
Moderators: Adnan Tufail and Ursula Schmidt-Erfurth

19:50 – 20:00  Summary 
Adnan Tufail (Moorfields Eye Hospital, UK)

20:00 – 20:10  Concluding remarks from the Co-Chairs